Insider Selling: Stevanato Group (NYSE:STVN) Insider Sells €293,453.50 in Stock

Stevanato Group S.p.A. (NYSE:STVN) insider Mauro Stocchi sold 13,649 shares of the business’s stock in a transaction dated Monday, September 28th. The shares were sold at an average price of €21.50, for a total value of €293,453.50. Following the completion of the sale, the insider directly owned 400,000 shares of the company’s stock, valued at €8,600,000. The trade was a 3.30% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Stevanato Group Stock Up 1.1%

Shares of NYSE:STVN opened at €20.20 on Friday. The business’s 50 day simple moving average is €21.11 and its two-hundred day simple moving average is €18.46. The firm has a market cap of $6.12 billion, a P/E ratio of 36.07, a PEG ratio of 1.63 and a beta of 0.78. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61. Stevanato Group S.p.A. has a 52-week low of €12.89 and a 52-week high of €27.99.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing analysts’ consensus estimates of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The firm had revenue of €302.00 million during the quarter. As a group, research analysts forecast that Stevanato Group S.p.A. will post 0.69 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have commented on STVN. UBS Group assumed coverage on shares of Stevanato Group in a research note on Wednesday, September 9th. They set a “neutral” rating and a $23.00 price target for the company. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Finally, Weiss Ratings upgraded shares of Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. Two equities research analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, Stevanato Group presently has an average rating of “Moderate Buy”.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of STVN. Integrated Wealth Concepts LLC bought a new stake in Stevanato Group in the 2nd quarter worth about $59,000. Squarepoint Ops LLC lifted its position in shares of Stevanato Group by 131.2% during the 2nd quarter. Squarepoint Ops LLC now owns 193,311 shares of the company’s stock worth $3,493,000 after buying an additional 109,702 shares in the last quarter. Wellington Management Group LLP purchased a new position in shares of Stevanato Group in the 2nd quarter worth approximately $22,621,000. Ranger Investment Management L.P. purchased a new position in shares of Stevanato Group in the 2nd quarter worth approximately $21,438,000. Finally, Handelsbanken Fonder AB grew its holdings in shares of Stevanato Group by 26.4% in the second quarter. Handelsbanken Fonder AB now owns 30,600 shares of the company’s stock valued at $553,000 after acquiring an additional 6,400 shares in the last quarter.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.